The 2017 Plague Outbreak in Madagascar drew international attention due to the high level of infections in densely populated areas and the unusually high prevalence of pneumonic plague.
GloPID-R mobilized early and activated its Response Plan, which is the network’s mechanism for a prompt and coordinated response by funders. Its Scientific Advisory Board (SAB) identified several research priorities and GloPID-R members then agreed on the most pressing of them.
Because the epidemic was contained, most of the needed research projects could not be implemented. But, upon a general call for assistance, two GloPID-R members (DFID and Wellcome Trust) mobilized immediate funding to assist Institut Pasteur to set up a “survivors” cohort. This project will be key to provide a meaningful evaluation of the outbreak and understand its clinical and immunologic history.